Depo-Provera

In some countries, this medicine may only be approved for veterinary use.

In the US, Depo-Provera (medroxyprogesterone systemic) is a member of the following drug classes: contraceptives, hormones/antineoplastics, progestins and is used to treat Abnormal Uterine Bleeding, Amenorrhea, Birth Control, Endometrial Cancer, Endometrial Hyperplasia - Prophylaxis, Endometriosis and Renal Cell Carcinoma.

US matches:

• Depo-Provera


• Depo-Provera Injectable Suspension


• Depo-Provera Contraceptive injectable


• Depo-Provera injectable


• Depo-Provera Contraceptive

UK matches:

• Depo-Provera 150 mg/ml Injection
• Depo-Provera 150mg/ml Injection (SPC)

Ingredient matches for Depo-Provera

Medroxyprogesterone

Medroxyprogesterone 17α-acetate (a derivative of Medroxyprogesterone) is reported as an ingredient of Depo-Provera in the following countries:

• Australia


• Bahrain


• Bangladesh


• Belgium


• Brazil


• Canada


• Colombia


• Czech Republic


• Denmark


• Ecuador


• Estonia


• Ethiopia


• Finland


• Georgia


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Ireland


• Israel


• Italy


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Netherlands


• New Zealand


• Norway


• Oman


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Singapore


• South Africa


• Sweden


• Switzerland


• Turkey


• United Kingdom


• United States


• Venezuela


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.